0001209191-22-001623.txt : 20220105
0001209191-22-001623.hdr.sgml : 20220105
20220105160219
ACCESSION NUMBER: 0001209191-22-001623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Martin
CENTRAL INDEX KEY: 0001640073
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 22511056
MAIL ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001640073
Edwards Martin
5320 LEGACY DRIVE
PLANO
TX
75024
1
0
0
0
Class A common stock
2022-01-03
4
A
0
59
27.32
A
59
D
Stock Option (right to buy)
27.32
2022-01-03
4
A
0
99
16.14
A
2032-01-03
Class A common stock
99
99
D
The shares represent Restricted Stock Units (RSU), which vest on June 8, 2022, subject to continued service through the vesting date.
These RSUs were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50.
The options vest in 2 equal installments on March 10, 2022 and June 10, 2022, subject to continued service through each vesting date.
These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $1,612.50.
/s/ Tracy Herson, attorney-in-fact
2022-01-05